Impaired capacity for endogenous fibrinolysis in essential hypertension

Lancet

Volumn 352, Issue 9140, 1998, Pages 1597-1598

  Hrafnkelsdóttir, Thórdís ^b   Wall, Ulrika ^b   Jern, Christina ^b   Jern, Sverker ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DESMOPRESSIN; METHACHOLINE; PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; ESSENTIAL HYPERTENSION; FIBRINOLYSIS; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0032517491     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(05)61044-6     Document Type: Article

References (5)

1. 1 Wall U, Jern S, Tengborn L, Jern C. Evidence of a local mechanism for desmopressin-induced tissue-type plasminogen activator release in human forearm. Blood 1998; 91: 529-37.
2. 2 Jern S, Selin L, Bergrant A, Jern C. Release of tissue-type plasminogen activator in response to muscarinic receptor stimulation in human forearm. Thromb Haemost 1994; 72: 588-94.
3. 3 Jern S, Wall U, Bergbrant A, Selin-Sjögren L, Jern C. Endothelium-dependent vasodilation and tissue-type plasminogen activator release in borderline hypertension. Arterioscler Thromb Vasc Biol 1997; 17: 3376-83.
4. 4 Emeis JJ. Regulation of the acute release of tissue-type plasminogen activator from the endothelium by coagulation activation products. Ann N Y Acad Sci 1992; 667: 249-58.
5. 5 Swan HJC. Acute myocardial infarction: a failure of timely, spontaneous thrombolysis. JACC 1989; 13: 1435-37.